Pfizer to manufacture Gilead’s Covid-19 drug candidate remdesivir

Pfizer has signed a multi-year agreement with Gilead Sciences to manufacture and supply the latter's investigational antiviral remdesivir for the treatment of Covid-19. Under the ... Read More